Kari Keese's Insider Trades & SAST Disclosures
Kari Keese's most recent trade in Axonics Inc was a trade of 40,362 Common Stock done at an average price of $71 . Disclosure was reported to the exchange on Nov. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kari Keese.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | Kari L. Keese | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 71.00 per share. | 15 Nov 2024 | 40,362 | 0 (0%) | 0% | 71 | 2,865,702 | Common Stock |
| Axonics Inc | Kari L. Keese | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 3,125 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Kari L. Keese | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.41 per share. | 02 Oct 2024 | 2,597 | 40,362 (0%) | 0% | 69.4 | 180,249 | Common Stock |
| Axonics Inc | Kari L. Keese | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.40 per share. | 02 Oct 2024 | 364 | 42,959 (0%) | 0% | 69.4 | 25,263 | Common Stock |
| Axonics Inc | Keese Kari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 6,167 | 46,812 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Kari Keese | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 4,167 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Kari Keese | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.74 per share. | 31 Jan 2024 | 3,489 | 43,323 (0%) | 0% | 67.7 | 236,331 | Common Stock |
| Axonics Inc | Kari Keese | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 2,000 | 0 | - | - | Performance-Based Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges